Date: Thursday, September 10, 2015
Time: 2:00 PM ET
Attendees joined this webinar for insight on 340B mega guidance and its effects. The Health Services and Resources Administration recently released its long-awaited mega guidance on the 340B Drug Pricing Program.
America’s Essential Hospitals’ 340B policy experts detailed the content of the guidance and its implications for essential hospitals.
Speakers:
Erin O’Malley
Director of Policy
America’s Essential Hospitals
Barbara Eyman, JD
Washington Counsel
America’s Essential Hospitals
Principal
Eyman Associates, PC
Sarah Mutinsky, JD, MPH
Deputy General Counsel,
America’s Essential Hospitals;
Founding Senior Advisor,
Eyman Associates, PC
Lisa Tofil, JD
Outside Counsel
America’s Essential Hospitals
Partner
Holland & Knight LLP
Suggested Participants:
All members of America’s Essential Hospitals were encouraged to attend, especially those serving in the following roles:
>> Please SIGN IN to make the webinar resources to appear on the right-hand side of this page.
For trouble accessing webinar materials, contact Alana Mallory | amallory@essentialhospitals.org.
Erin O’Malley
Director of Policy
America’s Essential Hospitals
>> Connect with Erin
Barbara Eyman, JD
Washington Counsel
America’s Essential Hospitals
Principal
Eyman Associates, PC
>> Connect with Barbara
Sarah Mutinsky, JD, MPH
Deputy General Counsel,
America’s Essential Hospitals;
Founding Senior Advisor,
Eyman Associates, PC
>> Connect with Sarah
Lisa Tofil, JD
Outside Counsel
America’s Essential Hospitals
Partner
Holland & Knight LLP
>> Connect with Lisa
All members of America’s Essential Hospitals were encouraged to attend, especially those serving in the following roles:
Sign in to view this webinar